Pharma Israel - The association representing the R&D-based multinational pharmaceutical companies operating in Israel

The organization represents multinational innovative pharmaceutical companies that are world leaders in the development of medicines, vaccines and medical technologies.

Pharma Israel’s main goal is to provide patients in Israel with greater access to medicines and to the most advanced technological developments in the world by striving to improve the regulatory environment of the innovative pharmaceutical industry, as well as to promote research and development activities in Israel.

Pharma Israel aims to be an active partner in policy-setting processes in the healthcare sector. It maintains frequent and fruitful dialogue with government ministries, public entities and organizations in Israel and abroad that engage with the healthcare sector in general and with the pharmaceutical industry in particular.

Since its foundation in 1999, Pharma Israel has taken an active part in increasing patients’ access to innovative original drugs in Israel; in improving and streamlining the drug registration process in Israel; in strengthening the intellectual property environment; in increasing the volume of clinical research in Israel and in promoting suitable conditions for expanding investments. These activities have significantly contributed to the position of Israel as a hub of medical research and an early adopter of breakthrough medicines and medical technologies. 

Our Vision

Pharma Israel aspires to bring early access to innovative medicines and technologies to patients in Israel; create a regulatory environment that supports medical innovation and matches international standards and expand the clinical trial activities and investments in the life sciences.

Pharma in Numbers

7000

New medicines in development around the world

2600000000

Cost of developing a new medicine (in US dollars)

1600

New clinical trials in Israel each year

620000000

New investments in clinical trials each year (in NIS)

  • Management
  • Board of Directors

Efrat Cohen CEO
Kesem Rozenblat External Relations and Project Manager
Ofri Epshtein Assistant to CEO

Dr. Meron Livne CEO, Pfizer Israel
Sharon Alon CEO, MSD Israel
Erez Shem Tov CEO, Merck Serono Israel
Orna Steinberger CEO, Boehringer Ingelheim